MacroGenics Announces Date Of Fourth Quarter And Full Year 2016 Financial Results Conference Call Post author:Sam Post published:February 16, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Booming Drug Sales Make This San Diego Biotech a Prime M&A Target November 2, 2017 Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active… December 14, 2017 When It Rains, It Pours: Bay Area's OncoMed Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study April 16, 2017
Pfizer Announces FDA Approval of XELJANZ (tofacitinib) and XELJANZ XR for the Treatment of Active… December 14, 2017
When It Rains, It Pours: Bay Area's OncoMed Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study April 16, 2017